These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10461350)

  • 1. The fate of released histamine: reception, response and termination.
    Rangachari PK
    Yale J Biol Med; 1998; 71(3-4):173-82. PubMed ID: 10461350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pharmacological aspects of histamine receptors.
    Leurs R; Smit MJ; Timmerman H
    Pharmacol Ther; 1995 Jun; 66(3):413-63. PubMed ID: 7494855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-linked receptors labeled by [3H]histamine in guinea pig cerebral cortex. I. Pharmacological characterization [corrected].
    Sinkins WG; Kandel M; Kandel SI; Schunack W; Wells JW
    Mol Pharmacol; 1993 Apr; 43(4):569-82. PubMed ID: 8285933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological significance of ECL-cell histamine.
    Andersson K; Chen D; Mattsson H; Sundler F; Håkanson R
    Yale J Biol Med; 1998; 71(3-4):183-93. PubMed ID: 10461351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contractile response of horse deep dorsal penile vein to histamine.
    Martínez AC; Prieto D; Hernández M; García-Sacristán A; Benedito S
    Int J Impot Res; 2002 Apr; 14(2):85-92. PubMed ID: 11979322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
    Sadek B; Elz S; Pertz HH; Stark H; Schunack W
    Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine: mercurial messenger in the gut.
    Rangachari PK
    Am J Physiol; 1992 Jan; 262(1 Pt 1):G1-13. PubMed ID: 1310220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemia of rat stomach mobilizes ECL cell histamine.
    Kitano M; Bernsand M; Kishimoto Y; Norlén P; Håkanson R; Haenuki Y; Kudo M; Hasegawa J
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1084-90. PubMed ID: 15662050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine and histaminergic ligands; a playground for medicinal chemists.
    Timmerman H
    Farmaco; 2002 Jul; 57(7):549-50. PubMed ID: 12164211
    [No Abstract]   [Full Text] [Related]  

  • 10. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
    Parmentier R; Anaclet C; Guhennec C; Brousseau E; Bricout D; Giboulot T; Bozyczko-Coyne D; Spiegel K; Ohtsu H; Williams M; Lin JS
    Biochem Pharmacol; 2007 Apr; 73(8):1157-71. PubMed ID: 17288995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal histamine and its receptors: implication of the pharmacological treatment of obesity.
    Masaki T; Yoshimatsu H
    Curr Med Chem; 2010; 17(36):4587-92. PubMed ID: 21062248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitatory effect of histamine on neuronal activity of rat globus pallidus by activation of H2 receptors in vitro.
    Chen K; Wang JJ; Yung WH; Chan YS; Chow BK
    Neurosci Res; 2005 Nov; 53(3):288-97. PubMed ID: 16143415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
    McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of neutrophil oxidative burst via histamine receptors.
    Cíž M; Lojek A
    Br J Pharmacol; 2013 Sep; 170(1):17-22. PubMed ID: 23336732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H3 receptor antagonists/inverse agonists as anti-obesity agents.
    Hancock AA
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1190-7. PubMed ID: 14649210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine in idiopathic inflammatory bowel diseases--not a standby player.
    Fogel W; Lewiński A; Jochem J
    Folia Med Cracov; 2005; 46(3-4):107-18. PubMed ID: 17252993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major advances in the development of histamine H4 receptor ligands.
    Smits RA; Leurs R; de Esch IJ
    Drug Discov Today; 2009 Aug; 14(15-16):745-53. PubMed ID: 19477292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal histamine H(3) receptors mediate antisecretory effects in the rat isolated gastric fundus.
    Adami M; Coruzzi G; Guaita E; Schunack W; Kitbunnadaj R; Timmermann H
    Inflamm Res; 2004 Mar; 53 Suppl 1():S25-6. PubMed ID: 15054602
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of histamine H3 receptors in the regulation of gastric functions.
    Coruzzi G; Morini G; Adami M; Grandi D
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):539-53. PubMed ID: 11787757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine protects against NMDA-induced necrosis in cultured cortical neurons through H receptor/cyclic AMP/protein kinase A and H receptor/GABA release pathways.
    Dai H; Zhang Z; Zhu Y; Shen Y; Hu W; Huang Y; Luo J; Timmerman H; Leurs R; Chen Z
    J Neurochem; 2006 Mar; 96(5):1390-400. PubMed ID: 16478529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.